P. Krawczyk

发表

Chronic obstructive pulmonary disease in farmers and agricultural workers - an overview.

M. Szczyrek, P. Krawczyk, J. Milanowski, 2011, Annals of agricultural and environmental medicine : AAEM.

Neoadjuvant and Adjuvant Immunotherapy in Non-Small Cell Lung Cancer—Clinical Trials Experience

P. Krawczyk, R. Ramlau, I. Chmielewska, 2021, Cancers.

Molecular and Clinical Premises for the Combination Therapy Consisting of Radiochemotherapy and Immunotherapy in Non-Small Cell Lung Cancer Patients

P. Krawczyk, J. Milanowski, E. Kalinka, 2021, Cancers.

Diagnostic Utility of PD-L1 and TP-53 mRNA As Well As microRNAs Expression in Liquid Biopsy of NSCLC Patients – Pilot Study

P. Krawczyk, J. Milanowski, B. Kuźnar-Kamińska, 2021 .

Two Complementarity Immunotherapeutics in Non-Small-Cell Lung Cancer Patients—Mechanism of Action and Future Concepts

P. Krawczyk, M. Strzemski, K. Wojas-Krawczyk, 2021, Cancers.

Aptamers in Non-Small Cell Lung Cancer Treatment

P. Krawczyk, K. Wojas-Krawczyk, I. Wieleba, 2020, Molecules.

Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures

P. Krawczyk, J. Milanowski, K. Wojas-Krawczyk, 2022, International journal of molecular sciences.

MET Gene Dysregulation as a Promising Therapeutic Target in Lung Cancer—A Review

P. Krawczyk, J. Milanowski, Paulina Terlecka, 2021, Journal of personalized medicine.

Sensitive methods for detection of the S768R substitution in exon 18 of the DDR2 gene in patients with central nervous system metastases of non-small cell lung cancer

P. Krawczyk, J. Milanowski, T. Trojanowski, 2014, Medical Oncology.

Polymorphisms in the Gene Encoding Caspase 8 May Predict the Response to First-Line Platinum-Based Chemotherapy in Locally Advanced or Advanced Non-Small-Cell Lung Cancer

M. Szczyrek, P. Krawczyk, J. Milanowski, 2021, Journal of clinical medicine.

Efficacy of Osimertinib in Lung Squamous Cell Carcinoma Patients with EGFR Gene Mutation–Case Report and a Literature Review

P. Krawczyk, J. Milanowski, I. Chmielewska, 2022, Current oncology.

Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer

P. Krawczyk, J. Milanowski, T. Trojanowski, 2016, Clinical and Translational Oncology.

Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study.

P. Krawczyk, J. Milanowski, J. Szumiło, 2018, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Only one step from tailored oncological therapies

P. Krawczyk, 2018, Nowotwory. Journal of Oncology.

The value of topotecan in the second-line treatment of small-cell lung cancer. Preliminary report

P. Krawczyk, J. Milanowski, A. Siwiec, 2010, Pneumonologia i Alergologia Polska.

Prognostic Value of Synaptophysin and Chromogranin A Expression in Patients Receiving Palliative Chemotherapy for Advanced Non-Small-Cell Lung Cancer

P. Krawczyk, W. Olszewski, M. Krzakowski, 2012, Respiration.

Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement

P. Krawczyk, J. Milanowski, I. Chmielewska, 2021, Scientific Reports.

Cytology Smears as Diagnostic Material for EGFR Gene Testing in Non-small Cell Lung Cancer

P. Krawczyk, J. Milanowski, J. Pankowski, 2015, Tumori.

[Effect of topotecan as a second line treatment in small cell lung cancer patients. Preliminary report].

P. Krawczyk, J. Milanowski, A. Siwiec, 2010, Pneumonologia i alergologia polska.

Predictive and prognostic factors in second- and third-line erlotinib treatment in NSCLC patients with known status of the EGFR gene.

M. Szczyrek, P. Krawczyk, J. Milanowski, 2013, Oncology reports.

EGFR gene mutations in patients with adenosquamous lung carcinoma

P. Krawczyk, J. Milanowski, R. Ramlau, 2014, Asia-Pacific journal of clinical oncology.

The relationship between polymorphisms of genes regulating DNA repair or cell division and the toxicity of platinum and vinorelbine chemotherapy in advanced NSCLC patients

P. Krawczyk, J. Milanowski, M. Prendecka, 2016, Clinical and Translational Oncology.

Pemetrexed in the treatment of non-small-cell lung cancer and malignant pleural mesothelioma

P. Krawczyk, M. Krzakowski, D. Kowalski, 2011 .

Rare co-existence of mutation in KRAS and ALK gene re-arrangement in an adenocarcinoma patient--a case report.

P. Krawczyk, J. Milanowski, E. Czekajska-Chehab, 2014, Anticancer research.

The Application of Real-Time PCR Technique to Detect Rare Cell Clones with Primary T790M Substitution of EGFR Gene in Metastases of Non-small Cell Lung Cancer to Central Nervous System in Chemotherapy Naive Patients

P. Krawczyk, J. Milanowski, T. Trojanowski, 2014, Pathology & Oncology Research.

The presence and clinical implications of α-2,6-galactose-linked sialic acids in non-small-cell lung cancer brain metastases--preliminary study.

P. Krawczyk, J. Szumiło, T. Trojanowski, 2014, Folia histochemica et cytobiologica.

Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations.

P. Krawczyk, J. Milanowski, R. Ramlau, 2017, Oncology letters.

Analysis of ROS1 gene rearrangement incidence among NSCLC patients with fluorescent in situ hybridization technique

P. Krawczyk, J. Milanowski, R. Ramlau, 2020 .

Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma

P. Krawczyk, J. Milanowski, R. Ramlau, 2021, Oncology letters.

The search for causes of resistance to pembrolizumab in lung adenocarcinoma with PD-L1 expression — focus on intestinal microbiome

P. Krawczyk, J. Milanowski, I. Chmielewska, 2020 .

TNF-alpha and TNF-beta gene polymorphisms in Polish patients with sarcoidosis. Connection with the susceptibility and prognosis.

P. Krawczyk, J. Milanowski, R. Kieszko, 2010, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

New Genetic Technologies in Diagnosis and Treatment of Cancer of Unknown Primary

P. Krawczyk, W. Olszewski, R. Dziadziuszko, 2022, Cancers.

Botulinum toxin in cancer therapy—current perspectives and limitations

P. Krawczyk, K. Kwiatek, T. Grenda, 2021, Applied Microbiology and Biotechnology.

Beta-2-adrenoreceptor polymorphism at position 16 determines the clinical severity of chronic obstructive pulmonary disease.

P. Krawczyk, J. Milanowski, A. Emeryk, 2017, Pulmonary pharmacology & therapeutics.

Myeloid and lymphoid dendritic cells and cytotoxic T lymphocytes in peripheral blood of non-small cell lung cancer patient--a pilot study.

P. Krawczyk, P. Milanowski, J. Roliński, 2006, Advances in medical sciences.

Cancer trigger or remedy: two faces of the human microbiome

P. Krawczyk, A. Grenda, 2021, Applied Microbiology and Biotechnology.

[Evaluation of Th1/Th2 lymphocyte balance and lipopolysaccharide receptor expression in asthma patients].

P. Krawczyk, J. Milanowski, T. Zaborowski, 2009, Pneumonologia i alergologia polska.

The impact of intestinal microflora on the effectiveness of immunotherapy with antibodies against immune checkpoints — case report and literature review

M. Szczyrek, P. Krawczyk, J. Milanowski, 2018, Oncology in Clinical Practice.

Tumor Microenvironment—A Short Review of Cellular and Interaction Diversity

P. Krawczyk, J. Milanowski, K. Wojas-Krawczyk, 2022, Biology.

Immunotherapy with pembrolizumab in a patient with advanced non-small-cell lung cancer with high PD-L1 expression and MET exon 14 splice site mutation: a case report

P. Krawczyk, J. Milanowski, I. Chmielewska, 2022, Oncology in Clinical Practice.

PD-L1 and TP-53 mRNA and microRNAs Expression in Liquid Biopsy of NSCLC Patients.

P. Krawczyk, J. Milanowski, B. Kuźnar-Kamińska, 2021 .

Lung Cancer Immunotherapy in Transplant Patients and in Patients With Autoimmune Diseases

P. Krawczyk, T. Kubiatowski, M. Nicoś, 2020, Frontiers in Oncology.

An Episode of Pseudothrombocytopenia during Pembrolizumab Therapy in NSCLC Patient

P. Krawczyk, J. Milanowski, I. Chmielewska, 2020, Case reports in oncological medicine.

PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients.

P. Krawczyk, J. Milanowski, J. Szumiło, 2019, Cancer genetics.

Do we apply a personalised lung cancer therapy? Use of molecular tests in scheduling a multilineage treatment in a patient with lung adenocarcinoma

M. Szczyrek, P. Krawczyk, J. Milanowski, 2017 .

Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer

M. Szczyrek, P. Krawczyk, J. Milanowski, 2022, AMB Express.

Diagnostic value of plasma expression of microRNAs complementary to Drosha and Dicer in lung cancer patients.

M. Szczyrek, P. Krawczyk, J. Milanowski, 2019, European review for medical and pharmacological sciences.

The clinical significance of interleukin 18 assessment in sarcoidosis patients.

P. Krawczyk, J. Milanowski, R. Kieszko, 2007, Respiratory medicine.

Dendritic cells stimulated by MUC1 antigen could induce lymphocytes' anergy through PD-L2 but not through PD-L1 patway.

P. Krawczyk, J. Milanowski, I. Homa-Mlak, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Risk factors and primary prevention of lung cancer. Cessation of cigarette addiction

P. Krawczyk, J. Milanowski, R. Ramlau, 2021, Oncology in Clinical Practice.

In vitro preliminary study on different anti-PD-1 antibody concentrations on T cells activation

P. Krawczyk, J. Milanowski, I. Chmielewska, 2022, Scientific reports.

The Yield of Endobronchial Biopsy in Pulmonary Sarcoidosis: Connection between Spirometric Impairment and Lymphocyte Subpopulations in Bronchoalveolar Lavage Fluid

P. Krawczyk, J. Milanowski, R. Kieszko, 2004, Respiration.

Differential diagnosis of autoimmune pituitary failure and pituitary macroadenoma during nivolumab therapy in an NSCLC patient — a case report

P. Krawczyk, J. Milanowski, R. Kieszko, 2019, Oncology in Clinical Practice.

Immunological system status and the appearance of respiratory system disturbances in thymectomized patients

P. Krawczyk, J. Milanowski, E. Korobowicz, 2007, Archivum Immunologiae et Therapiae Experimentalis.

HER2 gene assessment in liquid biopsy of gastric and esophagogastric junction cancer patients qualified for surgery

P. Krawczyk, J. Milanowski, G. Wallner, 2020, BMC Gastroenterology.

RET Proto-Oncogene—Not Such an Obvious Starting Point in Cancer Therapy

P. Krawczyk, A. Płużański, D. Kowalski, 2022, Cancers.

Immunotherapy in Non-Small-Cell Lung Cancer Patients with Driver Alterations: A New Strategy?

P. Krawczyk, J. Milanowski, K. Wojas-Krawczyk, 2022, Cells.

Rapid pathologic and molecular diagnosis of lung cancer patients based on telepathology techniques

P. Krawczyk, J. Milanowski, J. Pankowski, 2015 .

Interactions between Dietary Micronutrients, Composition of the Microbiome and Efficacy of Immunotherapy in Cancer Patients

P. Krawczyk, J. Milanowski, E. Kalinka, 2022, Cancers.

Experimental immunology Does the contamination of dendritic cells by lymphocytes skew the differentiation of monocytes into macrophages? A pilot study

P. Krawczyk, J. Milanowski, J. Roliński, 2008 .

Journal Pre-proof Genomic profiling identifies putative pathogenic alterations in non-small cell lung cancer brain metastases

Katarzyna, P. Krawczyk, J. Milanowski, 2022 .

Reply to the letter to the editor ‘ Prevalence of rare EGFR mutations in non-small cell lung cancer: a multicenter study on 3856 Polish Caucasian patients ’

P. Krawczyk, J. Milanowski, R. Ramlau, 2016 .

Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer--a pilot study.

P. Krawczyk, J. Milanowski, R. Mlak, 2012, Folia histochemica et cytobiologica.

Difficulties in the diagnosis of rare immunological diseases manifesting with cystic lung disease and spontaneous pneumothorax: Case reports.

P. Krawczyk, J. Milanowski, R. Kieszko, 2004, Heart & lung : the journal of critical care.

Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases

P. Krawczyk, J. Milanowski, J. Jassem, 2022, JTO clinical and research reports.

Effectiveness of Volatile Natural Deep Eutectic Solvents (VNADESs) for the Green Extraction of Chelidonium majus Isoquinoline Alkaloids

P. Krawczyk, R. Verpoorte, S. Dresler, 2022, Molecules.

In Vitro Antiproliferative Activity of Extracts of Carlina acaulis subsp. caulescens and Carlina acanthifolia subsp. utzka

P. Krawczyk, M. Latalski, M. Wójciak-Kosior, 2017, Front. Pharmacol..

Toxicity of Carlina Oxide—A Natural Polyacetylene from the Carlina acaulis Roots—In Vitro and in Vivo Study

P. Krawczyk, A. Michalak, S. Woźniak, 2020, Toxins.

Future Prospects of Immunotherapy in Non-Small-Cell Lung Cancer Patients: Is There Hope in Other Immune Checkpoints Targeting Molecules?

P. Krawczyk, J. Milanowski, K. Wojas-Krawczyk, 2022, International journal of molecular sciences.

Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients

M. Szczyrek, P. Krawczyk, J. Milanowski, 2021, Frontiers in Oncology.

Screening of Gene Mutations in Lung Cancer for Qualification to Molecularly Targeted Therapies

P. Krawczyk, Paweł Krawczyk, Tomasz Kucharczyk, 2012 .

Sensitive methods for the detection of an insertion in exon 20 of the HER2 gene in the metastasis of non-small cell lung cancer to the central nervous system

P. Krawczyk, J. Milanowski, T. Trojanowski, 2013, Oncology letters.

New Dancing Couple: PD‐L1 and MicroRNA

P. Krawczyk, A. Grenda, 2017, Scandinavian journal of immunology.

[The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations].

P. Krawczyk, W. Olszewski, R. Dziadziuszko, 2014, Pneumonologia i alergologia polska.

MicroRNAs aid the assessment of programmed death ligand 1 expression in patients with non-small cell lung cancer.

M. Szczyrek, P. Krawczyk, J. Milanowski, 2019, Oncology letters.

Genetic Clonality as the Hallmark Driving Evolution of Non-Small Cell Lung Cancer

P. Krawczyk, M. Nicoś, 2022, Cancers.

Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer

P. Krawczyk, K. Wojas-Krawczyk, M. Nicoś, 2021, International journal of molecular sciences.

Beyond PD-L1 Markers for Lung Cancer Immunotherapy

P. Krawczyk, J. Milanowski, E. Kalinka, 2019, International journal of molecular sciences.

Diet, Microbiome, and Cancer Immunotherapy—A Comprehensive Review

M. Szczyrek, P. Krawczyk, J. Milanowski, 2021, Nutrients.

Preventing central nervous system metastases in non-small cell lung cancer

P. Krawczyk, D. Kowalski, R. Duchnowska, 2018, Expert review of anticancer therapy.

Screening for gene mutations in central nervous system metastases of non‐small‐cell lung cancer

P. Krawczyk, J. Milanowski, J. Szumiło, 2018, Brain pathology.

Prevalence of NRAS, PTEN and AKT1 gene mutations in the central nervous system metastases of non-small cell lung cancer

P. Krawczyk, J. Milanowski, T. Trojanowski, 2017, Brain Tumor Pathology.

Septin 9 promoter region methylation in free circulating DNA—potential role in noninvasive diagnosis of lung cancer: preliminary report

Janusz Milanowski, P. Krawczyk, J. Milanowski, 2014, Medical Oncology.

Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes

P. Krawczyk, J. Milanowski, J. Szumiło, 2017, Oncotarget.

Methylation of DROSHA and DICER as a Biomarker for the Detection of Lung Cancer

M. Szczyrek, P. Krawczyk, J. Milanowski, 2021, Cancers.

The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings

M. Szczyrek, P. Krawczyk, J. Milanowski, 2015, Archives of medical science : AMS.

Application of plasma circulating microRNA-448, 506, 4316, and 4478 analysis for non-invasive diagnosis of lung cancer

P. Krawczyk, J. Milanowski, B. Kuźnar-Kamińska, 2016, Tumor Biology.

Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.

P. Krawczyk, J. Milanowski, D. Kowalski, 2015, Translational research : the journal of laboratory and clinical medicine.

Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer

P. Krawczyk, J. Milanowski, T. Trojanowski, 2015, Clinical and Experimental Medicine.

The presence of HER2 exon 20 insertion in patients with central nervous system metastases from non-small lung cancer--a potential application in classification for therapy.

P. Krawczyk, J. Milanowski, P. Milanowski, 2013, Pneumonologia i alergologia polska.

The Correlation of Mutations and Expressions of Genes within the PI3K/Akt/mTOR Pathway in Breast Cancer—A Preliminary Study

P. Krawczyk, A. Karczmarczyk, Anna Makuch-Kocka, 2021, International journal of molecular sciences.

Genetic and immune factors underlying the efficacy of cetuximab and panitumumab in the treatment of patients with metastatic colorectal cancer

P. Krawczyk, D. Kowalski, 2013, Contemporary oncology.

Molecularly targeted therapies in head and neck cancers.

M. Szczyrek, P. Krawczyk, J. Klatka, 2012, Otolaryngologia polska = The Polish otolaryngology.

Immunoprofiling: An Encouraging Method for Predictive Factors Examination in Lung Cancer Patients Treated with Immunotherapy

P. Krawczyk, J. Milanowski, K. Wojas-Krawczyk, 2021, International journal of molecular sciences.

The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors

P. Krawczyk, J. Milanowski, N. Crosetto, 2020, Frontiers in Oncology.

Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer

P. Krawczyk, J. Milanowski, D. Kowalski, 2012, Contemporary oncology.

Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in BRAF and p.R461* in NF1 Genes—A Case Report with Literature Review

P. Krawczyk, J. Milanowski, R. Kieszko, 2023, International journal of molecular sciences.

Innovations in lung cancer treatment

P. Krawczyk, A. Sienko, A. Bożyk, 2018 .

Effect of TOP2A and ERCC1 gene polymorphisms on the efficacy and toxicity of cisplatin and etoposide-based chemotherapy in small cell lung cancer patients

M. Szczyrek, P. Krawczyk, J. Milanowski, 2020, Archives of medical science : AMS.

Predictors of EGFR mutation and factors associated with clinical tumor stage at diagnosis: Experience of the INSIGHT study in Poland.

P. Krawczyk, J. Milanowski, W. Olszewski, 2017, Oncology letters.

Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients.

P. Krawczyk, J. Milanowski, R. Ramlau, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study

P. Krawczyk, J. Milanowski, R. Dziadziuszko, 2014, Journal of Cancer Research and Clinical Oncology.

Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients.

P. Krawczyk, J. Milanowski, R. Ramlau, 2013, Oncology reports.

Predictive value of ERCC 1 and RRM 1 gene single-nucleotide polymorphisms for first-line platinum-and gemcitabine-based chemotherapy in non-small cell lung cancer patients

P. Krawczyk, J. Milanowski, R. Ramlau, 2013 .

The Qualification of Docetaxel or Erlotinib for Second-Line Therapy Should Be Based on Clinical and Molecular Predictive Factors

P. Krawczyk, J. Milanowski, M. Krzakowski, 2012, Chemotherapy.

The Applicability of a Predictive Index for Second- and Third-Line Treatment of Unselected Non-Small-Cell Lung Cancer Patients

P. Krawczyk, J. Milanowski, M. Krzakowski, 2011, Respiration.

The clinical effect of chemotherapy in small cell lung cancer patient with four year survival. Case report

P. Krawczyk, J. Milanowski, B. Biernacka, 2009 .

Analysis of RTEL1 and PCDHGB6 promoter methylation in circulating-free DNA of lung cancer patients using liquid biopsy: A pilot study

P. Krawczyk, J. Milanowski, B. Kuźnar-Kamińska, 2016, Experimental lung research.

Phenotype of dendritic cells generated in the presence of non-small cell lung cancer antigens - preliminary report.

P. Krawczyk, J. Milanowski, J. Roliński, 2009, Folia histochemica et cytobiologica.

Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques--the Usefulness in the Qualification of Cancer Patients for Molecularly-Targeted Therapies.

P. Krawczyk, J. Milanowski, K. Wojas-Krawczyk, 2015, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non‐small cell lung cancer patients

M. Szczyrek, P. Krawczyk, J. Milanowski, 2019, Cancer medicine.

The influence of different culture microenvironments on the generation of dendritic cells from non-small-cell lung cancer patients

P. Krawczyk, J. Milanowski, J. Roliński, 2007, Archivum Immunologiae et Therapiae Experimentalis.

Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients

P. Krawczyk, P. Krawczyk, J. Milanowski, 2016, Clinical and Translational Oncology.

Immunotherapy of Lung Adenocarcinoma Patient with Peptide-Pulsed Dendritic Cells: a Case Report

P. Krawczyk, J. Milanowski, E. Czekajska-Chehab, 2012, Archivum Immunologiae et Therapiae Experimentalis.

Screening for ALK abnormalities in central nervous system metastases of non‐small‐cell lung cancer

P. Krawczyk, J. Milanowski, T. Trojanowski, 2018, Brain pathology.

Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer

P. Krawczyk, J. Szumiło, E. Szczurek, 2021, bioRxiv.

Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine

P. Krawczyk, J. Milanowski, R. Mlak, 2018, Pathology & Oncology Research.

Predictive value of STMN1 gene promoter polymorphism (−2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine

P. Krawczyk, J. Milanowski, M. Prendecka, 2015, Cancer Chemotherapy and Pharmacology.

Impact of I/D polymorphism of ACE gene on risk of development and course of chronic obstructive pulmonary disease

P. Krawczyk, J. Milanowski, R. Chazan, 2016, Archives of medical science : AMS.

Polymorphism of the ACE gene and the risk of obstructive sleep apnoea.

P. Krawczyk, J. Milanowski, I. Chmielewska, 2013, Pneumonologia i alergologia polska.

The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patients

P. Krawczyk, J. Milanowski, M. Grzybek, 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Tumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosis.

P. Krawczyk, J. Milanowski, J. Roliński, 2007, Respiratory medicine.

Effectiveness of ALK inhibitors in treatment of CNS metastases in NSCLC patients.

P. Krawczyk, M. Strzemski, M. Gil, 2023, Annals of medicine.

Lung Cancer in Poland.

P. Krawczyk, W. Olszewski, R. Dziadziuszko, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients

P. Krawczyk, J. Milanowski, R. Ramlau, 2015, Pathology & Oncology Research.

Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients.

P. Krawczyk, J. Milanowski, R. Ramlau, 2014, Clinical lung cancer.

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients

P. Krawczyk, J. Milanowski, R. Ramlau, 2014, Journal of Cancer Research and Clinical Oncology.

The relationship between RRM1 gene polymorphisms and effectiveness of gemcitabine-based first-line chemotherapy in advanced NSCLC patient

P. Krawczyk, J. Milanowski, M. Prendecka, 2015, Clinical and Translational Oncology.

Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer

P. Krawczyk, J. Milanowski, R. Ramlau, 2021, Archives of medical science : AMS.

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma

P. Krawczyk, J. Milanowski, R. Ramlau, 2013, Pathology & Oncology Research.

Evaluation of miR-506 and miR-4316 expression in early and non-invasive diagnosis of colorectal cancer

P. Krawczyk, J. Milanowski, D. Kowalski, 2017, International Journal of Colorectal Disease.

Reasons for delay in diagnosis and treatment of lung cancer among patients in Lublin Voivodeship who were consulted in Thoracic Surgery Department.

M. Szczyrek, P. Krawczyk, J. Milanowski, 2013, Annals of agricultural and environmental medicine : AAEM.

The Influence of Different Anti-PD-1 Monoclonal Antibody Concentrations On T Cell Activation in in - Vitro Culture – A Preliminary Study

P. Krawczyk, J. Milanowski, I. Chmielewska, 2021 .

Methodological recommendations for the diagnostics of EGFR gene mutations and ALK gene rearrangement in the selection of non-small-cell lung cancer patients to molecularly targeted therapies.

P. Krawczyk, R. Dziadziuszko, M. Krzakowski, 2014, Pneumonologia i alergologia polska.

Polymorphisms of Genes Encoding Multidrug Resistance Proteins as a Predictive Factor for Second-Line Docetaxel Therapy in Advanced Non-small Cell Lung Cancer

M. Szczyrek, P. Krawczyk, J. Milanowski, 2016, Pathology & Oncology Research.

The effectiveness of chemotherapy in small cell lung cancer patients with BRCA2 gene mutation and Schwartz-Bartter syndrome

P. Krawczyk, J. Milanowski, R. Kieszko, 2019, Oncology in Clinical Practice.

Retrospective analysis of second-line chemotherapy outcomes with paclitaxel or docetaxel in correlation with STMN1 polymorphism in advanced non-small cell lung cancer patients

P. Krawczyk, J. Milanowski, S. Barton, 2015, Clinical and Translational Oncology.

Discrepancies between ALK protein disruption and occurrence of ALK gene rearrangement in Polish NSCLC patients.

P. Krawczyk, J. Milanowski, R. Ramlau, 2018, Journal of thoracic disease.

Epidermal Growth Factor Receptor Mutation Status: Does Younger Mean More Frequently Mutated?

P. Krawczyk, J. Milanowski, R. Ramlau, 2017, Balkan Journal of Medical Genetics : BJMG.

Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients

M. Szczyrek, P. Krawczyk, J. Milanowski, 2022, Cancers.

Breaking the ‘Undruggable’ Barrier: Anti-PD-1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer Patients with KRAS Mutations—A Comprehensive Review and Description of Single Site Experience

P. Krawczyk, J. Milanowski, I. Chmielewska, 2023, Cancers.

Natural Bacterial and Fungal Peptides as a Promising Treatment to Defeat Lung Cancer Cells

P. Krawczyk, A. Jakubczyk, K. Rybczyńska-Tkaczyk, 2023, Molecules.

'TB or not TB?' Problems of differential diagnosis of cutaneous mycobacteriosis and tuberculosis--A Case Study and interdisciplinary discussion.

P. Krawczyk, J. Milanowski, Z. Zwolska, 2015, Annals of agricultural and environmental medicine : AAEM.

The diagnostic role of plasma circulating precursors of miRNA-944 and miRNA-3662 for non-small cell lung cancer detection.

P. Krawczyk, J. Milanowski, B. Kuźnar-Kamińska, 2017, Pathology, research and practice.

Questions around mutation T1010I in MET gene: results of next sequencing in Polish patient with suspected hereditary adenoid cystic carcinoma

P. Krawczyk, J. Milanowski, I. Chmielewska, 2020 .

Evaluation of ALK gene rearrangement in central nervous system metastases of non-small-cell lung cancer using two-step RT-PCR technique

P. Krawczyk, J. Milanowski, T. Trojanowski, 2017, Clinical and Translational Oncology.

Double Guard Efficiency and Safety—Overcoming Resistance to Immunotherapy by Blocking or Stimulating Several Immune Checkpoints in Non-Small Cell Lung Cancer Patients

P. Krawczyk, E. Kalinka, K. Wojas-Krawczyk, 2023, Cancers.

P2.01-66 Genomic Landscapes of DNA Copy Number Alterations in Primary Lung Cancers and Matched Brain Metastases

P. Krawczyk, J. Milanowski, J. Jassem, 2019, Journal of Thoracic Oncology.

The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients

P. Krawczyk, J. Milanowski, R. Ramlau, 2013, Contemporary oncology.

Beta-2-adrenoreceptor polymorphism at position 16 determines the clinical severity of chronic obstructive pulmonary disease.

P. Krawczyk, J. Milanowski, A. Emeryk, 2017, Pulmonary pharmacology & therapeutics.

The Applicability of a Predictive Index for Second- and Third-Line Treatment of Unselected Non-Small-Cell Lung Cancer Patients

P. Krawczyk, J. Milanowski, M. Krzakowski, 2011, Respiration.

Observational cross-sectional study of 5279 bronchoscopy results for the practical effectiveness of various biopsy techniques in the diagnosis of lung diseases with particular emphasis on lung cancer

P. Krawczyk, J. Milanowski, R. Kieszko, 2021, BMJ Open.

MicroRNAs aid the assessment of programmed death ligand 1 expression in patients with non-small cell lung cancer.

M. Szczyrek, P. Krawczyk, J. Milanowski, 2019, Oncology Letters.

Good's syndrome twelve years after thymectomy due to thymoma. A case study

P. Krawczyk, J. Milanowski, R. Ramlau, 2013 .

Phenotype of dendritic cells generated in the presence of non-small cell lung cancer antigens - preliminary report.

P. Krawczyk, J. Milanowski, J. Roliński, 2009, Folia histochemica et cytobiologica.

Efficacy of chemoimmunotherapy in a lung adenocarcinoma patient with mutations in the KRAS and STK11

P. Krawczyk, J. Milanowski, I. Chmielewska, 2023, Oncology in Clinical Practice.

The influence of plasma sPD-L1 concentration on the effectiveness of immunotherapy in advanced NSCLC patients

P. Krawczyk, J. Milanowski, I. Chmielewska, 2023, Cancer Immunology and Immunotherapy.

Replacement of ALK inhibitors as an effective strategy for reducing drug toxicity in non-small cell lung cancer patients with ALK gene rearrangement

P. Krawczyk, J. Milanowski, I. Chmielewska, 2023, Oncology in Clinical Practice.

Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection

P. Krawczyk, E. Kalinka, A. Grenda, 2024, International Journal of Molecular Sciences.

Variant Allele Frequency Analysis of Circulating Tumor DNA as a Promising Tool in Assessing the Effectiveness of Treatment in Non-Small Cell Lung Carcinoma Patients

P. Krawczyk, B. Kuźnar-Kamińska, M. Nicoś, 2024, Cancers.

Predictive factors testing proposal for NSCLC patients during the COVID-19 pandemic

P. Krawczyk, R. Dziadziuszko, D. Kowalski, 2021, Expert review of anticancer therapy.